Literature DB >> 8950672

Three histopathological types of retinoblastoma and their relation to heredity and age of enucleation.

A C Moll1, J W Koten, D A Lindenmayer, L A Everse, K E Tan, A Hamburg, J A Faber, W Den Otter.   

Abstract

The histopathology of 61 eyes was studied with special attention to the morphology of the retina adjacent to the main tumour. Three retinal types were distinguished. Retina type 1 (RT-1, 28 specimens) contained a single tumour that was sharply demarcated from surrounding normal retina. In retina type 2 (RT-2, 29 specimens) large parts of the retina were affected and the main tumour mass gradually blended with the adjacent pathological retina. Retina type 3 (RT-3, four specimens) was characterised by a retina almost entirely affected by diffuse tumour growth. RT-1 correlated significantly with early enucleation (0-3 years) both in hereditary and non-hereditary cases. RT-2 was seen in eyes enucleated later (2-5 years). The progressing tumour may release growth factors in the intraocular space that stimulate the cells of the adjacent retina and lead to multiple new primary tumours in the adjacent retinal area. RT-3 was only present in non-hereditary cases with late enucleation (at 2-5 years). Hereditary retinoblastoma cases are usually detected early. Therefore in hereditary cases RT-1 is significantly more common than RT-2. In 25 eyes of the 44 patients with unilateral sporadic retinoblastoma, multifocal tumours of the retina were observed. Such cases should not mistakenly be classified as hereditary cases on the basis of the histological pattern of multifocality of the tumour process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950672      PMCID: PMC1050786          DOI: 10.1136/jmg.33.11.923

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Associated congenital malformations in retinoblastoma.

Authors:  C Bonaïtti-Pellié; M L Briard-Guillemot; J Feingold; J Frézal
Journal:  Clin Genet       Date:  1975-01       Impact factor: 4.438

2.  Hereditary retinoblastoma: penetrance, expressivity and age of onset.

Authors:  E Matsunaga
Journal:  Hum Genet       Date:  1976-07-07       Impact factor: 4.132

3.  Spontaneous pseudohypopyon secondary to diffuse infiltrating retinoblastoma.

Authors:  J A Shields; C L Shields; R C Eagle; C J Blair
Journal:  Arch Ophthalmol       Date:  1988-09

4.  Diffuse infiltrating retinoblastoma.

Authors:  G Morgan
Journal:  Br J Ophthalmol       Date:  1971-09       Impact factor: 4.638

5.  Non-ocular cancer in patients with hereditary retinoblastoma and their relatives.

Authors:  D J DerKinderen; J W Koten; N J Nagelkerke; K E Tan; F A Beemer; W Den Otter
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

6.  The management of unilateral retinoblastoma without primary enucleation.

Authors:  D H Abramson; R F Marks; R M Ellsworth; P Tretter; F D Kitchin
Journal:  Arch Ophthalmol       Date:  1982-08

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 8.  Genetics of retinoblastoma.

Authors:  F Vogel
Journal:  Hum Genet       Date:  1979-11-01       Impact factor: 4.132

9.  Spectrum of small length germline mutations in the RB1 gene.

Authors:  D R Lohmann; B Brandt; W Höpping; E Passarge; B Horsthemke
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

10.  Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas.

Authors:  T P Dryja; J M Rapaport; J M Joyce; R A Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more
  1 in total

1.  Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; M Gerick; B Brandt; U Oelschläger; B Lorenz; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.